Details for Patent: 11,918,685
✉ Email this page to a colleague
Which drugs does patent 11,918,685 protect, and when does it expire?
Patent 11,918,685 protects KATERZIA and is included in one NDA.
This patent has five patent family members in five countries.
Drugs Protected by US Patent 11,918,685
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Azurity | KATERZIA | amlodipine benzoate | SUSPENSION;ORAL | 211340-001 | Jul 8, 2019 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | A METHOD OF TREATING CORONARY ARTERY DISEASE | ⤷ Subscribe | ||||
| Azurity | KATERZIA | amlodipine benzoate | SUSPENSION;ORAL | 211340-001 | Jul 8, 2019 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | A METHOD OF TREATING HYPERTENSION | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,918,685
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 3096101 | ⤷ Subscribe | |||
| China | 112334134 | ⤷ Subscribe | |||
| European Patent Office | 3773574 | ⤷ Subscribe | |||
| Japan | 2021520367 | ⤷ Subscribe | |||
| World Intellectual Property Organization (WIPO) | 2019200143 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
